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WITH modern cytotoxic therapy,
remissions in adult leukaemia are achieved
more readily (Beard and Fairley, 1974),
and this raises the problem of how to
manage leukaemia when it presents during
pregnancy, in view ofthe potential foeto-
toxic effects of cytotoxic drugs. Since
there are few reports (Maurer, 1971;
Raich and Curet, 1975; Pawlinger, 1971)
of pregnant leukaemic patients being
treated with modern cytotoxic agents,
we describe such a case, to demonstrate
that it is possible to use these drugs in a
pregnant patient during the second and
third trimesters, without overt damage to
the foetus.
A 38-year-old Italian woman presented
in the 20th week of her second pregnancy
with a two-month history ofa widespread,
discrete, papular violaceous rash, progres-
sive tiredness and weakness. Biopsy of
a skin nodule was difficult to interpret, but
showed malignant mononuclear cell infil-
tration. Her Hb was 9-9 g/dl and her
WWC 6-0 x 109/1, with a monocytosis
of 3-5 x 109/1. Three weeks later she pre-
sented to this hospital with an uncertain
diagnosis; by this time she had developed
a right Bell's palsy, marked gum hyper-
trophy and aworsening oftherash. There
was no lymphadenopathy nor hepatos-
plenomegaly. The pregnancy was progress
ing normally. Her Hb remainedstable but
her WCC rose to 22-10 x 109/1 with
15'0 x 109/1 monoblasts: her platelets
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were 230 x 109/1. The bone marrowfind-
ings were typical of acute monocytic
leukaemia with 80% blast cells which
were strongly Sudan Black positive.
Gingival biopsy showed infiltration with
primitive mononuclear cells. Staining of
the blood monocytes, bone marrow, gin-
gival and skin biopsies by the immuno-
peroxidase method showed the monocytes
to contain large amounts of lysozyme
(Mason and Taylor, 1975). The urine
also contained excessive amounts of lyso-
zyme, measured as 680 ,ug/ml (normal
less than 1 jtg/ml).
It was considered unsafe to terminate
the pregnancy at this time owing to the
potential hazards of haemorrhage and
infection. She was entered into the
sixth Medical Research Council acute
myeloid leukaemia trial and bone marrow
remission was induced with six 5-day
courses of daunorubicin (DR) 120 mg i.v.
on Day 1, and cytosine arabinoside
(Ara C) 160 mg i.v. daily for 5 days, the
courses being repeated at 5-day intervals.
She received a post-remission course ofthe
same drugs. This was followed by a skin
relapse, treated with a further single
course ofDR and Ara C, and subsequently
two 5-day courses of thioguanine (6TG)
160 mg daily and Ara C 160 mg daily.
During this period of treatment, from
23 to 37 weeks of gestation, she had
frequent blood transfusions in order to
maintain her haemoglobin above 10 g/dl.
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FIG. Scalp hair samples from (a) mother, (b) newborn infant, as seen at a magnification of x 1000
under the scanning microscope. The mother's hair shows fractured cuticular squames, which
appear thickened with irregular margins. The infant's hair appears normal: it is narrower in
calibre than adult hair: the free margins of the cuticular squames show the normal delicate charac-
teristics. Some artifactual debris is present on the hair surfaces in places.
She also received treatment with i.v.
antibiotics including gentamicin for sus-
pected septicaemia. The right Bell's
palsy gradually recovered to normal; no
leukaemic cells were found in the C.S.F.
The pregnancy was monitored clinic-
ally, with the addition of frequent hor-
monal estimations. Serial ultrasonic
measurements offoetal biparietal diameter
revealed normal growth. At 37 weeks of
gestation the patient had completed her
tenth course of cytotoxic therapy and was
haematologically normal. At this time a
palmitic acid level in the liquor amnii was
37 ng/ml, indicating little risk of the
foetus developing idiopathic respiratory
distresssyndrome (MacLennan etal., 1975).
Labour was induced and a healthy, nor-
mal, male infant weighing 2880 g was
spontaneously delivered. Total blood loss
was estimated at about 150 ml. The
infant's Hb, WCC and platelet counts
were normal. He is now 16 months old
and his growth and development are
normal. The mother relapsed haemato-
logically in July 1975, and despite further
treatment died on 20.12.75.
On the day of delivery, samples of
hair were taken from the mother and her
infant for study under the scanning
electron microscope. The mother's newly
grown hair (adjacent to the bulb) showed
fractured cuticular squames, features
which have been seen previously in
patients on cytotoxic therapy (Baum and
Harris, 1975). The child's hair appeared
normal throughout its length (Fig.).
The mother's blood leucocyte chromo-
somes were studied at the time ofdelivery
and showed evidence of random chromo-
some breakages, as seen in patients on
cytotoxic therapy; the infant's cord blood
leucocyte chromosomes appeared normal.
DISCUSSION
The incidence of leukaemia in preg-
nancy is low. One in 1000 pregnancies is
complicated by cancer (Rothman, Cohen
and Astarloa, 1973) and evidence of
leukaemia in pregnancy would be expected
to be less than 1 in 75,000 pregnancies.
Approximately 300 pregnancies associated
with leukaemia have been reported
(McLain, 1974), with a poor outcome in
acute leukaemia. An induction regime
using DR and Ara C is currently the
commonly-used form of therapy for acute
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myelogenous/monocytic leukaemia. Such
agents have been shown to be toxic to
foetal tissue in experimental animals
(Chaube and Murphy, 1965; Roux and
Taillemite, 1969; Roux, Emerit and
Taillemite, 1971). A foetus with trisomy
for Group C was born to a mother treated
with Ara C and 6TG in large doses during
the second trimester of pregnancy
(Maurer, 1971). Malformations have
occurred after treatment with cytotoxic
drugs in the first trimester (Sokal and
Lessman, 1960; Nicholson, 1968). In
spite of this evidence, other published
data suggest that anti-leukaemic therapy
can safely be undertaken after the first
trimester (Pawlinger, 1971; Sukal and
Lessman, 1960; Nicholson, 1968).
In our case the newborn was clinically
normal and has subsequently grown
normally. Neonatal hair studied under
the scanning microscope was normal and
showed no evidence of any cytotoxic
damage as was observed in the mother's
hair. Since the foetus first develops hair
around 20 weeks of gestation (Baum,
Hughes and Harris, 1974), this observa-
tion suggests that the foetus had not been
exposed to significant doses of cytotoxic
drugs in the last 17 weeks of pregnancy.
However, we know of no evidence as to
the minimum cytotoxic dose necessary
to produce visible evidence of damage to
human hair squames. The absence of
breakages of the cord blood leucocyte
chromosomes, which were present in
matrnal leucocytes atthetime ofdelivery,
also suggest that the foetus had not been
exposed to a significant cytotoxic drug
dosage.
At present there is no evidence that
pregnancy has any deleterious effect on
leukaemia (Nicholson, 1968; Frenkel and
Meyers, 1960). Hence the association
of leukaemia and pregnancy is in itself
not enough reason to terminate a preg-
nancy. The leukaemia affects the preg-
nancy in terms of increased risk of infec-
tion, abortion and haemorrhage from
hypofibrinogenaemia, disseminated intra-
vascular coagulation and thrombocyto-
penia (Ewing and Whittaker, 1975). In
this case it was considered that the risks
of haemorrhage and infection associated
with termination exceeded those of con-
tinuing the pregnancy, at least until a
remission was achieved. The parents
were consulted on the moral issue oftermi-
nation of the pregnancy. They were
informed ofthe potential risks ofthe cyto-
toxic drugs to the foetus, the very poor
maternal prognosis and the very small
risk of subsequent leukaemia in the infant
(Cramblett, Friedman and Nayyar, 1958;
Hoover and Schumacher, 1966). Follow-
ing this discussion, they were adamant
to proceed with the pregnancy.
Wewouldadvocatethat, inaspecialized
centre, a pregnant leukaemic woman
should be treated with aggressive chemo-
therapy until a remission is achieved.
If therapy is started in the first trimester,
the risk of a malformed foetus may be
high and termination should be considered
once in remission. If therapy is started
in the second or third trimester the foetus
may develop normally and the decision
to terminate must be made on moral and
medico-social grounds. We speculatively
suggest that amniocentesis might provide
foetal cells for examination for chromo-
somal breakage and foetal hair for scan-
ning electron microscopy, as guides to
foetal damage when therapy had been
started early in the second trimester.
The offspring of such patients should be
followed up for neoplasia and possible
DR-induced cardiotoxicity.
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